Lilly adds suicide risk to Strattera (Reuters)


Reuters - Eli Lilly and Co. on Thursday said it
will add strong warnings to its label for Strattera, used to
treat attention-deficit/hyperactivity disorder, including the
risk of suicidal thoughts among children and adolescents.